Pfizer rivals face uphill struggle
October 24, 2003Pharmaceutical companies attempting to keep up with Pfizer's industry lead have a battle on their hands, according to analysts Datamonitor.New …
Why can’t pharma be more like this?
October 24, 2003Research and Development, Sales and Marketing branding, corporate
Brands are compressed bytes of information. They contain myriad messages that create impressions. If these impressions net out in a …
Industry concern over EU reform
October 24, 2003A serious lack of progress in EU moves to reform pharmaceutical regulation is now jeopardising key objectives, according to European …
FDA to streamline approval process
October 24, 2003The FDA has launched a programme to speed up approval of new drugs in response to growing concerns about lengthening …
GSK productivity picking up
October 24, 2003GlaxoSmithKline's early-stage pipeline of new drugs has shown big improvements recently, according to analysts Deutsche Bank."These metrics could be taken …
R&D outsourcing strategies
October 24, 2003Research and Development CRO, contract research, contract research organisation
The R&D and sales and marketing functions of major pharma companies are suffering from declining productivity. To date, the industry's …
AstraZeneca sets aside $350m in fraud case
October 24, 2003AstraZeneca has set aside $350 million to cover costs relating to its alleged defrauding of the US Medicare and Medicaid …
Take-off for e-detailing?
October 24, 2003Sales and Marketing e-detailing
It started last autumn with a complaint. An anonymous GP protested to the ABPI's Prescription Medicines Code of Practice Authority …
The Persuaders
October 24, 2003Sales and Marketing sales, sales force
Long time the province of Steve Coogan (grrr, I'm a tiger) and, more recently, Ricky Gervais in 'The Office', sales …
Keeping an eye on the incubators
October 24, 2003Research and Development CRO, contract research, contract research organisation
Pharmaceutical companies are increasingly outsourcing their clinical trials to contract research organisations (CROs). There are more than 1,000 CROs world-wide, …
Need a replacement? Consider the options
October 24, 2003Business Services interim management, recruitment
When looking to replace someone in a key, high-value role, the recruitment process can often be put in place without …
CRM – how to do it right
October 24, 2003Sales and Marketing CRM, customer relationship management
Management wants a single view of all customers and all products, reps want a single view of the customer they …
Parlez-vous business?
October 23, 2003Sales and Marketing marketing
There is no doubt about it – the world really is getting smaller. Multinational companies continue to expand and it …
Pharmafocus e-detailing survey
October 23, 2003Sales and Marketing e-detailing, survey
The e-detailing survey has now closed and the winner in the prize draw will be notified in due course.The results …
Campaigning for awareness
October 23, 2003Medical Communications disease awareness campaigns
With the vast number of different stakeholders involved in the healthcare sector, trying to pin down a strict definition of …
The way forward for clinical research
October 23, 2003Research and Development NICE, clinical research, healthcare
Clinical investigators in drug development have made enormous contributions to the advancement of healthcare over the last 25 years, and …
Do as I say, not as I do?
October 23, 2003Research and Development management, pay, pharma
The new regulations requiring companies to put their remuneration committee reports to shareholder vote is starting to have a significant …
Union discontent over NHS pay deal
October 23, 2003Three major healthcare worker unions have expressed their dissatisfaction with the Government pay deal for more than a million NHS …
Dry pipelines undermining EMEA
October 23, 2003A dramatic drop in new drug applications is now threatening Europe's medicines regulator the EMEA with a financial crisis, and …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
